Therapeutic options for newly diagnosed multiple myeloma / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
;
(12): 389-391, 2008.
Artículo
en Chino
| WPRIM
| ID: wpr-471307
ABSTRACT
According to the latest classification of International Myeloma Working Group(IMWG),multiple myeloma(MM)is roughly classified into two groups,asymptomatic myeloma(smoldering myeloma)and symptomatic myeloma.The former is equal to the stage Ⅰ of Durie-Salmon(DS),and patients of this type only wait and see,and do not need any therapy.The later is equal to stage Ⅱ and Ⅲ of DS,and patients of this type need therapy immediately.Autologous stem cell transplantation(ASCT)is recommended by National Comprehensive Cancer Network(NCCN)for patients with stage Ⅱ or Ⅲ myeloma with good performance status in 2007.Different therapeutic regiwen should he selected for newly diagnosed MM patients according to whether ASCT is suitable or not.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio diagnóstico
Idioma:
Chino
Revista:
Journal of Leukemia & Lymphoma
Año:
2008
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS